Suffern strange deal
We raised a question at last year’s Novartis AGM, and have not yet found a satisfactory answer as to who profited by $12 million from a most peculiar property sale. In a written response, Novar... »
-
-
-
-
-
-
-
-
-
-
Slide #23
-
Slide #24
-
-
Latest Posts
Sandoz – Mixed Messages?
At the Forbes Healthcare Summit in New York in November 2018, Vasant Narasimhan, CEO of Novartis explained how his strategy is to narrow his focus to make Novartis a “breakthrough ... »
Credit Suisse – Messy House?
A few years ago Credit Suisse sent me a final DEMAND letter threatening dire consequences if I did not settle my outstanding balance. They already blocked my cards. The letter was signed (passi... »
